Minireview: Physiological and pathological actions of RAS in the ovary

Molecular Endocrinology

Volumn 24, Issue 2, 2010, Pages 286-298

  Fan, Heng Yu ^a   Richards, JoAnne S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADOTROPIN; K RAS PROTEIN; LUTEINIZING HORMONE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAS PROTEIN; TRANSCRIPTION FACTOR FKHR; WNT PROTEIN;

CARCINOGENESIS; CELL CYCLE ARREST; ENZYME ACTIVATION; FEMALE INFERTILITY; GENE EXPRESSION; GENE MUTATION; GRANULOSA CELL; HUMAN; NONHUMAN; OVARY; OVARY CANCER; OVARY CELL CULTURE; OVARY DISEASE; OVARY FOLLICLE; OVULATION; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENE KNOCK-IN TECHNIQUES; HUMANS; MALE; MICE; MICE, KNOCKOUT; OVARIAN DISEASES; OVARIAN NEOPLASMS; OVARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); RAS PROTEINS;

RODENTIA;

EID: 75149139491     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0251     Document Type: Short Survey

References (80)

1. Bos JL 1988 The ras gene family and human carcinogenesis. Mutat Res 195:255-271
2. Barbacid M 1987 Ras genes. Annu Rev Biochem 56:779-827
3. Hall A 1993 Ras-related proteins. Curr Opin Cell Biol 5:265-268
4. Erdogan M, Pozzi A, Bhowmick N, Moses HL, Zent R 2007 Signaling pathways regulating TC21-induced tumorigenesis. J Biol Chem 282:27713-27720
5. Keduka E, Kaiho A, Hamada M, Watanabe-Takano H, Takano K, Ogasawara M, Satou Y, Satoh N, Endo T 2009 M-Ras evolved independently of R-Ras and its neural function is conserved between mammalian and ascidian, which lacks classical Ras. Gene 429:49-58
6. Lehto M, Mäyränpää MI, Pellinen T, Ihalmo P, Lehtonen S, Kovanen PT, Groop PH, Ivaska J, Olkkonen VM 2008 The R-Ras interaction partner ORP3 regulates cell adhesion. J Cell Sci 121:695-705
7. Umanoff H, Edelmann W, Pellicer A, Kucherlapati R 1995 The murine N-ras gene is not essential for growth and development. Proc Natl Acad Sci USA 92:1709-1713
8. Ise K, Nakamura K, Nakao K, Shimizu S, Harada H, Ichise T, Miyoshi J, Gondo Y, Ishikawa T, Aiba A, Katsuki M 2000 Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 19:2951-2956
9. Koera K, Nakamura K, Nakao K, Miyoshi J, Toyoshima K, Hatta T, Otani H, Aiba A, Katsuki M 1997 K-ras is essential for the development of the mouse embryo. Oncogene 15:1151-1159
10. Campbell PM, Groehler AL, Lee KM, Ouellette MM, Khazak V, Der CJ 2007 K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res 67:2098-2106
11. Céspedes MV, Sancho FJ, Guerrero S, Parreño M, Casanova I, Pavón MA, Marcuello E, Trias M, Cascante M, Capellà G, Mangues R 2006 K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12. Carcinogenesis 27:2190-2200
12. Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, Nye E, Stamp G, Alitalo K, Downward J 2007 Binding of Ras to phosphoinositide 3-kinase p110α is required for Ras-driven tumorigenesis in mice. Cell 129:957-968
13. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW 1997 Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602
14. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, Hollstein PE, MacCollin M, Cichowski K 2006 A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10:459-472
15. Courtois-Cox S, Jones SL, Cichowski K 2008 Many roads lead to oncogene-induced senescence. Oncogene 27:2801-2809
16. Wayne CM, Fan HY, Cheng X, Richards JS 2007 Follicle-stimulating hormone induces multiple signaling cascades: evidence that activation of Rous sarcoma oncogene, RAS, and the epidermal growth factor receptor are critical for granulosa cell differentiation. Mol Endocrinol 21:1940-1957
17. Needle E, Piparo K, Cole D, Worrall C, Whitehead I, Mahon G, Goldsmith LT 2007 Protein kinase A-independent cAMP stimulation of progesterone in a luteal cell model is tyrosine kinase dependent but phosphatidylinositol-3-kinase and mitogen-activated protein kinase independent. Biol Reprod 77:147-155
18. Fan HY, Shimada M, Liu Z, Cahill N, Noma N, Wu Y, Gossen J, Richards JS 2008 Selective expression of KrasG12D in granulosa cells of the mouse ovary causes defects in follicle development and ovulation. Development 135:2127-2137
19. Fan HY, Liu Z, Paquet M, Wang J, Lydon JP, DeMeyo F, Richards JS 2009 Cell type-specific targeted mutations of Kras and Pten document proliferation arrest in granulosa cells versus oncogenic insult to ovarian surface epithelial cells. Cancer Res 69:6463-6472
20. Hunzicker-Dunn M, Maizels ET 2006 FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal 18:1351-1359
21. Richards JS 1994 Hormonal control of gene expression in the ovary. Endocr Rev 15:725-751
22. Matzuk MM, Burns KH, Viveiros MM, Eppig JJ 2002 Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 296:2178-2180
23. Richards JS 2001 New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol 15:209-218
24. Gonzalez-Robayna IJ, Falender AE, Ochsner S, Firestone GL, Richards JS 2000 Follicle-stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-induced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells. Mol Endocrinol 14:1283-1300
25. Charest PG, Oligny-Longpré G, Bonin H, Azzi M, Bouvier M 2007 The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling. Cell Signal 19:32-41
26. Wang Q, Lu R, Zhao J, Limbird LE 2006 Arrestin serves as a molecular switch, linking endogenous α2-adrenergic receptor to SRC-dependent, but not SRC-independent, ERK activation. J Biol Chem 281:25948-25955
27. Miller WE, Lefkowitz RJ 2001 Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr Opin Cell Biol 13:139-145
28. Shiraishi K, Ascoli M 2006 Activation of the lutropin/ choriogonadotropin receptor in MA-10 cells stimulates tyrosine kinase cascades that activate ras and the extracellular signal regulated kinases (ERK1/2). Endocrinology 147:3419-3427
29. Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M 2004 EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 303:682-684
30. Hernandez-Gonzalez I, Gonzalez-Robayna I, Shimada M, Wayne CM, Ochsner SA, White L, Richards JS 2006 Gene expression profiles of cumulus cell oocyte complexes during ovulation reveal cumulus cells express neuronal and immune-related genes: does this expand their role in the ovulation process? Mol Endocrinol 20:1300-1321
31. Shimada M, Hernandez-Gonzalez I, Gonzalez-Robayna I, Richards JS 2006 Paracrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: key roles for prostaglandin synthase 2 and progesterone receptor. Mol Endocrinol 20:1352-1365
32. Hsieh M, Lee D, Panigone S, Horner K, Chen R, Theologis A, Lee DC, Threadgill DW, Conti M 2007 Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol Cell Biol 27:1914-1924
33. Espey LL, Richards JS 2002 Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat. Biol Reprod 67:1662-1670
34. Fan HY, Liu Z, Shimada M, Sterneck E, Johnson PF, Hedrick SM, Richards JS 2009 MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science 324:938-941
35. Panigone S, Hsieh M, Fu M, Persani L, Conti M 2008 Luteinizing hormone signaling in preovulatory follicles involves early activation of the epidermal growth factor receptor pathway. Mol Endocrinol 22:924-936
36. Sterneck E, Tessarollo L, Johnson PF 1997 An essential role for C/EBPβ in female reproduction. Genes Dev 11:2153-2162
37. Mantena SR, Kannan A, Cheon YP, Li Q, Johnson PF, Bagchi IC, Bagchi MK 2006 C/EBPβ is a critical mediator of steroid hormone-regulated cell proliferation and differentiation in the uterine epithelium and stroma. Proc Natl Acad Sci USA 103:1870-1875
38. Schaffler A, Scholmerich J, Salzberger B 2007 Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol 28:393-399
39. Sebastian T, Malik R, Thomas S, Sage J, Johnson PF 2005 C/EBPβ cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. EMBO J 24:3301-3312
40. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS 2008 Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:1019-1031
41. Liu Z, de Matos DG, Fan HY, Shimada M, Palmer S, Richards JS 2009 IL6: an autocrine regulator of the mouse cumulus cell-oocyte complex expansion process. Endocrinology 150:3360-3368
42. Duggavathi R, Volle DH, Mataki C, Antal MC, Messaddeq N, Auwerx J, Murphy BD, Schoonjans K 2008 Liver receptor homolog 1 is essential for ovulation. Genes Dev 22:1871-1876
43. Jeyasuria P, Ikeda Y, Jamin SP, Zhao L, De Rooij DG, Themmen AP, Behringer RR, Parker KL 2004 Cell-specific knockout of steroidogenic factor 1 reveals its essential roles in gonadal function. Mol Endocrinol 18:1610-1619
44. Lee YK, Choi YH, Chua S, Park YJ, Moore DD 2006 Phosphorylation of the hinge domain of the nuclear hormone receptor LRH-1 stimulates transactivation. J Biol Chem 281:7850-7855
45. Su YQ, Wigglesworth K, Pendola FL, O'Brien MJ, Eppig JJ 2002 Mitogen-activated protein kinase activity in cumulus cells is essential for gonadotropin-induced oocyte meiotic resumption and cumulus expansion in the mouse. Endocrinology 143:2221-2232
46. Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA 2007 Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9:493-505
47. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, Tuveson DA, Jacks T 2001 Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410:1111-1116
48. Haigis KM, Kendall KR, Wang Y, Cheung A, Haigis MC, Glickman JN, Niwa-Kawakita M, Sweet-Cordero A, Sebolt-Leopold J, Shannon KM, Settleman J, Giovannini M, Jacks T 2008 Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet 40:600-608
49. Tuveson DA, Shaw AT, Willis NA, Silver DP, Jackson EL, Chang S, Mercer KL, Grochow R, Hock H, Crowley D, Hingorani SR, Zaks T, King C, Jacobetz MA, Wang L, Bronson RT, Orkin SH, DePinho RA, Jacks T 2004 Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5:375-387
50. Shaw AT, Meissner A, Dowdle JA, Crowley D, Magendantz M, Ouyang C, Parisi T, Rajagopal J, Blank LJ, Bronson RT, Stone JR, Tuveson DA, Jaenisch R, Jacks T 2007 Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis. Genes Dev 21:694-707
51. Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS, Varmus HE 2002 Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 1:53-62
52. Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, Hamilton TC 2003 Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63:1389-1397
53. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T 2005 Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11:63-70
54. Wu R, Hendrix-Lucas N, Kuick R, Zhai Y, Schwartz DR, Akyol A, Hanash S, Misek DE, Katabuchi H, Williams BO, Fearon ER, Cho KR 2007 Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/β-catenin and PI3K/Pten signaling pathways. Cancer Cell 11:321-333
55. Pieretti-Vanmarcke R, Donahoe PK, Pearsall LA, Dinulescu DM, Connolly DC, Halpern EF, Seiden MV, MacLaughlin DT 2006 Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer. Proc Natl Acad Sci USA 103:17426-17431
56. Jorgez CJ, Klysik M, Jamin SP, Behringer RR, Matzuk MM 2004 Granulosa cell-specific inactivation of follistatin causes female fertility defects. Mol Endocrinol 18:953-967
57. Hernandez Gifford JA, Hunzicker-Dunn ME, Nilson JH 2009 Conditional deletion of β-catenin mediated by Amhr2cre in mice causes female infertility. Biol Reprod 80:1282-1292
58. Fan HY, Liu Z, Cahill N, Richards JS 2008 Targeted disruption of Pten in ovarian granulosa cells enhances ovulation and extends the life span of luteal cells. Mol Endocrinol 22:2128-2140
59. Soyal SM, Mukherjee A, Lee KY, Li J, Li H, DeMayo FJ, Lydon JP 2005 Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis 41:58-66
60. Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, Zevenhoven J, Berns A 2007 p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448:943-946
61. Sebastian T, Johnson PF 2006 Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPβ. Cell Cycle 5:953-957
62. Ancrile B, Lim KH, Counter CM 2007 Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 21:1714-1719
63. Kurman RJ, Shih IeM 2008 Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol 27:151-160
64. Vanderhyden BC, Shaw TJ, Ethier JF 2003 Animal models of ovarian cancer. Reprod Biol Endocrinol 1:67
65. Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvili G, Zhao Y, Zeng T, Glover JN, Vanderhyden B, Zhao C, Parkinson CA, Jimenez-Linan M, Bowtell DD, Mes-Masson AM, Brenton JD, Aparicio SA, Boyd N, Hirst M, Gilks CB, Marra M, Huntsman DG 2009 Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 360:2719-2729
66. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A 1992 α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-319
67. Li Q, Graff JM, O'Connor AE, Loveland KL, Matzuk MM 2007 SMAD3 regulates gonadal tumorigenesis. Mol Endocrinol 21:2472-2486
68. Pangas SA, Li X, Umans L, Zwijsen A, Huylebroeck D, Gutierrez C, Wang D, Martin JF, Jamin SP, Behringer RR, Robertson EJ, Matzuk MM 2008 Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 28:248-257
69. Boerboom D, Paquet M, Hsieh M, Liu J, Jamin SP, Behringer RR, Sirois J, Taketo MM, Richards JS 2005 Misregulated Wnt/β-catenin signaling leads to ovarian granulosa cell tumor development. Cancer Res 65:9206-9215
70. Boerboom D, White LD, Dalle S, Courty J, Richards JS 2006 Dominant-stable β-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model. Cancer Res 66:1964-1973
71. Cantley LC, Neel BG 1999 New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240-4245
72. Li G, Robinson GW, Lesche R, Martinez-Diaz H, Jiang Z, Rozengurt N, Wagner KU, Wu DC, Lane TF, Liu X, Hennighausen L, Wu H 2002 Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129:4159-4170
73. Richards JS, Sharma SC, Falender AE, Lo YH 2002 Expression of FKHR, FKHRL1, and AFX genes in the rodent ovary: evidence for regulation by IGF-I, estrogen, and the gonadotropins. Mol Endocrinol 16:580-599
74. Shi F, LaPolt PS 2003 Relationship between FoxO1 protein levels and follicular development, atresia, and luteinization in the rat ovary. J Endocrinol 179:195-203
75. Laguë MN, Paquet M, Fan HY, Kaartinen MJ, Chu S, Jamin SP, Behringer RR, Fuller PJ, Mitchell A, Doré M, Huneault LM, Richards JS, Boerboom D 2008 Synergistic effects of Pten loss and WNT/CT-NNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression. Carcinogenesis 29:2062-2072
76. Wang Y, Cheon DJ, Lu Z, Cunningham SL, Chen CM, Luo RZ, Xing D, Orsulic S, Bast Jr RC, Behringer RR 2008 MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse. Differentiation 76:1081-1092
77. Kumar TR, Low MJ, Matzuk MM 1998 Genetic rescue of follicle-stimulating hormone β-deficient mice. Endocrinology 139:3289-3295
78. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH 1995 Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 92:1322-1326
79. Bliss SP, Miller A, Navratil AM, Xie J, McDonough SP, Fisher PJ, Landreth GE, Roberson MS 2009 ERK signaling in the pituitary is required for female but not male fertility. Mol Endocrinol 23:1092-1101
80. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J 2008 Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6:2853-2868